Rgenta Therapeutics Form D (2026)

Summary

The SEC Form D for Rgenta Therapeutics, filed on 2026-11-03, reports $41,852,307 raised. The legal name on the form is Rgenta Therapeutics, Inc. The form does not name the purchasers. Filing: https://www.sec.gov/Archives/edgar/data/1801266/000123191926001529/0001231919-26-001529-index.htm

Year of incorporation on the form: more than five years ago. Securities on the form: equity; debt. That wording is not stored as a round type. Earlier Form D filings, if any, are not combined. The issuer city on the form is Woburn. It is not stored as a headquarters.

This page is not indexed by search engines yet because the filing does not name the purchasers.

Investors

Sources

Last verified: 2026-11-04

1. https://www.sec.gov/Archives/edgar/data/1801266/000123191926001529/0001231919-26-001529-index.htm
   Type: sec filing. Accessed 2026-11-04.
   SEC Form D for Rgenta Therapeutics, Inc. EDGAR filing date 2026-11-03. Acceptance time on the index page: 2026-11-03 15:26:44. Signed 2026-11-03 by Hualin S. Xi, Chief Executive Officer. First sale 2026-10-19. A new notice, not an amendment. Total amount sold $41,852,307 of an offering amount of $130,107,279. 9 investors already invested. Issuer address city is Woburn, Massachusetts. Jurisdiction on the form: Delaware. Entity type on the form: Corporation. Year of incorporation on the form: more than five years ago. The form does not name the purchasers or a round type. Street addresses and phone numbers are not published. Securities on the form: equity; debt. That wording is not stored as a round type. Related persons use the names in the issue. Earlier Form D filings, if any, are not combined.
2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-11-04/
   Type: other verified public source. Accessed 2026-11-04.
   Raise Track Update for 2026-11-04, Section 3. Lists Rgenta Therapeutics in Massachusetts, industry Other Technology, amount raised $41,852,307.